- Condition: Myelodysplastic Syndrome (MDS)
Intervention: Drug: Azacitidine
Sponsors: Celgene Corporation; Celgene Corporation; PRA International
Not yet recruiting - verified May 2012 - Condition: Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Intervention: Procedure: Liver resection plus Thrombectomy
Sponsors: Sun Yat-sen University; Sun Yat-sen University; Guangzhou Eight People's Hospital; Kaiping central hospital; The 458 Hospital of Chinese People's Liberation Army
Completed - verified May 2012 - Condition: Anemia in Chronic Kidney Disease
Interventions: Drug: FG-4592; Drug: Placebo
Sponsors: FibroGen; FibroGen
Recruiting - verified May 2012 - Condition: Transfusion Related Complications
Interventions: Other: Transfusion trigger based on POTTS; Other: Maintenance of hemoglobin level more than 10g/dL; Other: Transfusion trigger based on experience
Sponsors: West China Hospital; West China Hospital
Enrolling by invitation - verified May 2012 - Condition: Biliary Tract Neoplasm
Intervention: Device: Magnetic resonance imaging, GE Signa, 3.0 T
Sponsors: China Medical University, China; China Medical University, China
Recruiting - verified May 2012 - Condition: Hepatitis B
Interventions: Drug: Entecavir; Drug: Peginterferon alfa-2a
Sponsors: Sun Yat-sen University; Sun Yat-sen University
Not yet recruiting - verified May 2012 - Conditions: Nasopharyngeal Squamous Cell Carcinoma; Toxicity Due to Radiotherapy
Interventions: Drug: gemcitabine and cisplatin; Drug: docetaxel and cisplatin
Sponsors: Fourth Military Medical University; Fourth Military Medical University
Recruiting - verified May 2012 - Condition: Pulmonary Hypertension
Interventions: Drug: iloprost nebuliser solution; Drug: distilled water
Sponsors: Shanghai Jiao Tong University School of Medicine; Shanghai Jiao Tong University School of Medicine; Cardiothoracic Surgical Group of Chinese Society of Pediatric Surgery
Not yet recruiting - verified May 2012 - Condition: Pancreatic Cancer
Interventions: Drug: Mirtazapine plus gemcitabine; Drug: Gemcitabine, placebo
Sponsors: Tianjin Medical University Cancer Institute and Hospital; Tianjin Medical University Cancer Institute and Hospital
Not yet recruiting - verified May 2012 - Conditions: Coronary Artery Disease; Coronary Artery Bypass Graft
Interventions: Drug: Tranexamic Acid; Drug: Saline
Sponsors: Cardiovascular Institute & Fuwai Hospital; Li Lihuan
Completed - verified May 2012 - Condition: Multiple Myeloma
Interventions: Drug: Lenalidomide; Drug: Dexamethasone
Sponsors: Celgene Corporation; Celgene Corporation
Active, not recruiting - verified May 2012 - Condition: Acute Pancreatitis
Interventions: Device: AN69 hemofilter; Other: conventional treatments
Sponsors: Fourth Military Medical University; Fourth Military Medical University
Recruiting - verified May 2012 - Condition: Prostate Cancer
Interventions: Drug: Placebo and prednisone; Drug: Abiraterone acetate and prednisone
Sponsors: Janssen Research & Development, LLC; Janssen Research & Development, LLC
Recruiting - verified May 2012 - Conditions: Advanced Neoplasm; MicroRNA-21 (miR-21) and miR-92
Intervention:
Sponsors: Chinese University of Hong Kong; Chinese University of Hong Kong
Recruiting - verified May 2012 - Condition: Gastroesophageal Varice
Interventions: Procedure: Ligation and Cyanoacrylate; Procedure: Ligation plus Sclerotherapy and Cyanoacrylate Group
Sponsors: Shanghai Zhongshan Hospital; Shanghai Zhongshan Hospital
Recruiting - verified May 2012 - Condition: Anemia in End Stage Renal Disease
Interventions: Drug: FG-4592; Drug: Epoetin Alfa
Sponsors: FibroGen; FibroGen; Ruijin Hospital; RenJi Hospital; Chang Zheng Hospital; XinHua Hospital; Peking University First Hospital; First Affiliated Hospital, Sun Yat-Sen University; Zhejiang University No 1. Hospital; Peking Union Medical College Hospital; Shenzhen People's Hospital
Recruiting - verified May 2012 - Condition: Metastatic Breast Cancer
Interventions: Drug: Capecitabine; Drug: Etoposide
Sponsors: Peking University; Tao OUYANG
Not yet recruiting - verified May 2012 - Condition: Uterine Fibroids
Intervention: Device: MR-HIFU uterine fibroid treatment
Sponsors: Philips Healthcare; Philips Healthcare
Not yet recruiting - verified April 2012 - Conditions: Respiratory Tract Infections; Urinary Tract Infections
Interventions: Drug: Ceftazidime and Sulbactam Sodium (High dose); Drug: Ceftazidime and Sulbactam Sodium (Low dose); Drug: Cefoperazone and Sulbactam Sodium (CFP/SUB)
Sponsors: Xiangbei Welman Pharmaceutical Co., Ltd; Xiangbei Welman Pharmaceutical Co., Ltd
Recruiting - verified April 2012 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin (Scilin N, BAY81-9924); Drug: Insulin (Scilin R _BAY81-9924; Drug: Insulin(Scilin M30_BAY81-9924)
Sponsors: Bayer; Bayer
Not yet recruiting - verified April 2012 - Condition: Hormone Refractory Prostate Cancer
Intervention:
Sponsors: Zhengzhou University; Zhengzhou University; The First Affiliated Hospital of Zhengzhou University; the cancer hospital of Zhengzhou University; the fifth affiliated hospital of Zhengzhou University; People's hospital of Zhengzhou University; Zhengzhou central hospital affiliated to Zhengzhou University; Zhengzhou people's hospial; Xinyang central hospital; Zhoukou central hospital; the second people's hospital of kaifeng
Recruiting - verified May 2012 - Condition: Irregular Antibody Screening
Intervention:
Sponsors: Johnson & Johnson Medical, China; Johnson & Johnson Medical, China
Not yet recruiting - verified April 2012 - Condition: Lung Cancer
Intervention: Drug: Neoadjuvant Bevacizumab
Sponsors: Sun Yat-sen University; Siyu Wang
Recruiting - verified April 2012 - Conditions: Bacterial Infection Due to Helicobacter Pylori (H. Pylori); Peptic Ulcer Bleeding
Intervention:
Sponsors: Chinese University of Hong Kong; Chinese University of Hong Kong
Completed - verified May 2012 - Condition: Colorectal Neoplasms
Interventions: Drug: Regorafenib (BAY73-4506); Drug: Placebo
Sponsors: Bayer; Bayer
Not yet recruiting - verified April 2012 - A Repeated Instruction by Telephone on the Day Before Colonoscopy to Patients Undergoing ColonoscopyConditions: Bowel Preparation Score; Adenoma
Intervention: Other: telephone education
Sponsors: Fourth Military Medical University; Fourth Military Medical University
Recruiting - verified April 2012 - Condition: Myopia
Intervention: Device: Corneal power measurement
Sponsors: Wenzhou Medical College; Wenzhou Medical College
Completed - verified January 2011 - Condition: Osteoarthritis
Intervention: Drug: Hylan G-F 20 (Synvisc)
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified April 2012 - Condition: Rectal Cancer
Intervention: Drug: Amifostine
Sponsors: Chinese Academy of Medical Sciences; Chinese Academy of Medical Sciences
Recruiting - verified April 2012 - Conditions: Supraventricular Tachycardia; Atrioventricular Nodal Reentrant Tachycardia
Interventions: Procedure: cryoablation; Procedure: radiofrequency ablation
Sponsors: Princess Margaret Hospital, Hong Kong; Princess Margaret Hospital, Hong Kong
Recruiting - verified April 2012 - Condition: Rectal Neoplasms
Interventions: Drug: capecitabine; Drug: Capecitabine; Drug: Capecitabine; Drug: Capecitabine; Drug: Capecitabine
Sponsors: Chinese Academy of Medical Sciences; Chinese Academy of Medical Sciences
Recruiting - verified April 2012 - Condition: Hepatitis C
Intervention:
Sponsors: Johnson & Johnson Medical, China; Johnson & Johnson Medical, China
Recruiting - verified April 2012 - Condition: Pancreatic Pseudocyst
Intervention: Procedure: EUS-guided pancreatic pseudocyst drainage
Sponsors: Fourth Military Medical University; Xiaoyin Zhang
Recruiting - verified April 2012 - Condition: Rectal Cancer
Intervention:
Sponsors: Chinese Academy of Medical Sciences; Chinese Academy of Medical Sciences
Recruiting - verified April 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Vildagliptin; Drug: Placebo
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Condition: Esophageal Squamous Cell Carcinoma
Interventions: Drug: Paclitaxel plus 5-fluorouracil; Drug: Cisplatin plus 5-fluorouracil; Radiation: Radiation therapy; Radiation: Radiation therapy
Sponsors: Fudan University; Fudan University
Recruiting - verified May 2012 - Condition: Acute Lung Injury
Interventions: Procedure: noninvasive positive pressure ventilation; Procedure: oxygen therapy
Sponsors: Beijing Hospital; Beijing Hospital
Not yet recruiting - verified April 2012 - Condition: Heroin Addiction
Interventions: Drug: JITAI Combined with psychological intervention; Drug: Methadone; Drug: Traditional Chinese Medicine JITAI
Sponsors: Shanghai Mental Health Center; Shanghai Mental Health Center; Shanghai Center of Biomedicine Development
Recruiting - verified April 2012 - Conditions: Meningitis; Influenza
Interventions: Biological: A+C+hib Conjugate Vaccine; Biological: Placebo; Biological: A+C Vaccine; Biological: Hib vaccine
Sponsors: Jiangsu Province Centers for Disease Control and Prevention; Jiangsu Province Centers for Disease Control and Prevention; Royal (Wuxi) Biological Co., LTD
Recruiting - verified April 2012
 |
Find Paid Clinical Trials in Alabama |
Clinical Trial Locations 